These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


152 related items for PubMed ID: 10525409

  • 1. Structure of recombinant mouse collagenase-3 (MMP-13).
    Botos I, Meyer E, Swanson SM, Lemaître V, Eeckhout Y, Meyer EF.
    J Mol Biol; 1999 Oct 01; 292(4):837-44. PubMed ID: 10525409
    [Abstract] [Full Text] [Related]

  • 2. High-resolution solution structure of the catalytic fragment of human collagenase-3 (MMP-13) complexed with a hydroxamic acid inhibitor.
    Moy FJ, Chanda PK, Chen JM, Cosmi S, Edris W, Levin JI, Powers R.
    J Mol Biol; 2000 Sep 22; 302(3):671-89. PubMed ID: 10986126
    [Abstract] [Full Text] [Related]

  • 3. Crystal structure of the stromelysin catalytic domain at 2.0 A resolution: inhibitor-induced conformational changes.
    Chen L, Rydel TJ, Gu F, Dunaway CM, Pikul S, Dunham KM, Barnett BL.
    J Mol Biol; 1999 Oct 29; 293(3):545-57. PubMed ID: 10543949
    [Abstract] [Full Text] [Related]

  • 4. Crystal structure of human macrophage elastase (MMP-12) in complex with a hydroxamic acid inhibitor.
    Nar H, Werle K, Bauer MM, Dollinger H, Jung B.
    J Mol Biol; 2001 Sep 28; 312(4):743-51. PubMed ID: 11575929
    [Abstract] [Full Text] [Related]

  • 5. 1.56 A structure of mature truncated human fibroblast collagenase.
    Spurlino JC, Smallwood AM, Carlton DD, Banks TM, Vavra KJ, Johnson JS, Cook ER, Falvo J, Wahl RC, Pulvino TA.
    Proteins; 1994 Jun 28; 19(2):98-109. PubMed ID: 8090713
    [Abstract] [Full Text] [Related]

  • 6. Structure of malonic acid-based inhibitors bound to human neutrophil collagenase. A new binding mode explains apparently anomalous data.
    Brandstetter H, Engh RA, Von Roedern EG, Moroder L, Huber R, Bode W, Grams F.
    Protein Sci; 1998 Jun 28; 7(6):1303-9. PubMed ID: 9655333
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.
    Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK.
    J Med Chem; 1997 Mar 14; 40(6):1026-40. PubMed ID: 9083493
    [Abstract] [Full Text] [Related]

  • 8. NMR solution structure of the catalytic fragment of human fibroblast collagenase complexed with a sulfonamide derivative of a hydroxamic acid compound.
    Moy FJ, Chanda PK, Chen JM, Cosmi S, Edris W, Skotnicki JS, Wilhelm J, Powers R.
    Biochemistry; 1999 Jun 01; 38(22):7085-96. PubMed ID: 10353819
    [Abstract] [Full Text] [Related]

  • 9. Sultam hydroxamates as novel matrix metalloproteinase inhibitors.
    Cherney RJ, Mo R, Meyer DT, Hardman KD, Liu RQ, Covington MB, Qian M, Wasserman ZR, Christ DD, Trzaskos JM, Newton RC, Decicco CP.
    J Med Chem; 2004 Jun 03; 47(12):2981-3. PubMed ID: 15163180
    [Abstract] [Full Text] [Related]

  • 10. Crystal structures of the catalytic domain of human stromelysin-1 (MMP-3) and collagenase-3 (MMP-13) with a hydroxamic acid inhibitor SM-25453.
    Kohno T, Hochigai H, Yamashita E, Tsukihara T, Kanaoka M.
    Biochem Biophys Res Commun; 2006 May 26; 344(1):315-22. PubMed ID: 16603129
    [Abstract] [Full Text] [Related]

  • 11. Hydroxamate-based peptide inhibitors of matrix metalloprotease 2.
    Jani M, Tordai H, Trexler M, Bányai L, Patthy L.
    Biochimie; 2005 May 26; 87(3-4):385-92. PubMed ID: 15781326
    [Abstract] [Full Text] [Related]

  • 12. High-resolution solution structure of the inhibitor-free catalytic fragment of human fibroblast collagenase determined by multidimensional NMR.
    Moy FJ, Chanda PK, Cosmi S, Pisano MR, Urbano C, Wilhelm J, Powers R.
    Biochemistry; 1998 Feb 10; 37(6):1495-504. PubMed ID: 9484219
    [Abstract] [Full Text] [Related]

  • 13. Pyran-containing sulfonamide hydroxamic acids: potent MMP inhibitors that spare MMP-1.
    Reiter LA, Robinson RP, McClure KF, Jones CS, Reese MR, Mitchell PG, Otterness IG, Bliven ML, Liras J, Cortina SR, Donahue KM, Eskra JD, Griffiths RJ, Lame ME, Lopez-Anaya A, Martinelli GJ, McGahee SM, Yocum SA, Lopresti-Morrow LL, Tobiassen LM, Vaughn-Bowser ML.
    Bioorg Med Chem Lett; 2004 Jul 05; 14(13):3389-95. PubMed ID: 15177439
    [Abstract] [Full Text] [Related]

  • 14. X-ray structures of human neutrophil collagenase complexed with peptide hydroxamate and peptide thiol inhibitors. Implications for substrate binding and rational drug design.
    Grams F, Reinemer P, Powers JC, Kleine T, Pieper M, Tschesche H, Huber R, Bode W.
    Eur J Biochem; 1995 Mar 15; 228(3):830-41. PubMed ID: 7737183
    [Abstract] [Full Text] [Related]

  • 15. Peptides of type II collagen can induce the cleavage of type II collagen and aggrecan in articular cartilage.
    Yasuda T, Tchetina E, Ohsawa K, Roughley PJ, Wu W, Mousa A, Ionescu M, Pidoux I, Poole AR.
    Matrix Biol; 2006 Sep 15; 25(7):419-29. PubMed ID: 16919430
    [Abstract] [Full Text] [Related]

  • 16. Quantitative structure-activity relationship of human neutrophil collagenase (MMP-8) inhibitors using comparative molecular field analysis and X-ray structure analysis.
    Matter H, Schwab W, Barbier D, Billen G, Haase B, Neises B, Schudok M, Thorwart W, Schreuder H, Brachvogel V, Lönze P, Weithmann KU.
    J Med Chem; 1999 Jun 03; 42(11):1908-20. PubMed ID: 10354399
    [Abstract] [Full Text] [Related]

  • 17. Crystal structure of human MMP9 in complex with a reverse hydroxamate inhibitor.
    Rowsell S, Hawtin P, Minshull CA, Jepson H, Brockbank SM, Barratt DG, Slater AM, McPheat WL, Waterson D, Henney AM, Pauptit RA.
    J Mol Biol; 2002 May 24; 319(1):173-81. PubMed ID: 12051944
    [Abstract] [Full Text] [Related]

  • 18. N-Hydroxyurea as zinc binding group in matrix metalloproteinase inhibition: mode of binding in a complex with MMP-8.
    Campestre C, Agamennone M, Tortorella P, Preziuso S, Biasone A, Gavuzzo E, Pochetti G, Mazza F, Hiller O, Tschesche H, Consalvi V, Gallina C.
    Bioorg Med Chem Lett; 2006 Jan 01; 16(1):20-4. PubMed ID: 16242329
    [Abstract] [Full Text] [Related]

  • 19. Substrate specificity determinants of human macrophage elastase (MMP-12) based on the 1.1 A crystal structure.
    Lang R, Kocourek A, Braun M, Tschesche H, Huber R, Bode W, Maskos K.
    J Mol Biol; 2001 Sep 28; 312(4):731-42. PubMed ID: 11575928
    [Abstract] [Full Text] [Related]

  • 20. Structural basis of the matrix metalloproteinases and their physiological inhibitors, the tissue inhibitors of metalloproteinases.
    Bode W, Maskos K.
    Biol Chem; 2003 Jun 28; 384(6):863-72. PubMed ID: 12887053
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.